Project Name：Rivaroxaban 

Registration Classification：3+6

Formulations and specifications ：Tablets: 10mg 

Indications：For the prevention of  deep vein thrombosis (DVT) and pulmonary embolism (PE) formation after hip and knee replacement surgery.

Original Research Company：Bayer

Progress ：Recently reported to the State Bureau